Effectiveness and safety of citalopram in hospitalized adolescents with major depression: A preliminary, 8-week, fixed-dose, open-label, prospective study

Gal Shoval*, Eitan Nahshoni, Doron Gothelf, Iris Manor, Pavel Golobchik, Zvi Zemishlany, Abraham Weizman, Gil Zalsman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Effectiveness and safety of citalopram in hospitalized adolescents with major depression: A preliminary, 8-week, fixed-dose, open-label, prospective study'. Together they form a unique fingerprint.

Keyphrases

Neuroscience